Answer
Melphalan is associated with a later risk of myelodysplastic syndrome, acute myeloid leukaemia and some other malignancies. Clinicians balance this risk against the expected treatment benefit.
Sources for this answer
- Melphalan 2 mg Tablets — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.